CYTK
CYTOKINETICS INC
Company overview
- Market capitalization
- $9.20B
- Employees
- 673
- Latest publication
- 2026-09-29
About CYTOKINETICS INC
Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q3 20202020-09-30 · USD | Q4 20172017-12-31 · USD | Q4 20162016-12-31 · USD | Q3 20162016-09-30 · USD | Q4 20142014-12-31 · USD | Q4 20132013-12-31 · USD | Q2 20122012-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 28,624,000USD | 41,688,000USD | -18,000USD | 33,138,000USD | 59,047,000USD | 21,758,000USD | 24,349,000USD | 1,841,000USD |
| Research Development | 97,807,000USD | 24,202,000USD | 26,251,000USD | 18,776,000USD | 19,340,000USD | 8,779,000USD | 13,824,000USD | 8,242,000USD |
| Selling General Administrative | 104,397,000USD | 12,302,000USD | 10,259,000USD | 6,675,000USD | 7,217,000USD | 4,558,000USD | 4,093,000USD | 2,568,000USD |
| Total Operating Expenses | 207,796,000USD | 12,302,000USD | 10,258,000USD | 2,173,999USD | 7,217,000USD | 4,558,000USD | 4,093,000USD | 10,810,000USD |
| Operating Income | -179,172,000USD | 5,184,000USD | -36,527,000USD | 7,688,000USD | 32,490,000USD | 8,421,000USD | 6,432,000USD | -8,956,000USD |
| Total Other Income Expense Net | 13,941,000USD | -8,359,000USD | -3,958,000USD | -531,000USD | -603,000USD | 22,000USD | 99,000USD | 13,000USD |
| Net Income | -198,762,000USD | -3,175,000USD | -40,485,000USD | 7,157,000USD | 31,887,000USD | 8,443,000USD | 6,531,000USD | -8,943,000USD |
| Cost Of Revenue | 2,731,000USD | 24,202,000USD | 26,251,000USD | 23,276,000USD | 19,340,000USD | 8,779,000USD | 13,824,000USD | 10,666,000USD |
| Gross Profit | — | 17,486,000USD | -26,269,000USD | 9,862,000USD | 39,707,000USD | 12,979,000USD | 10,525,000USD | 1,841,000USD |
| Unclassified Operating Expenses | — | -24,202,000USD | -26,252,000USD | -23,277,001USD | -19,340,000USD | -8,779,000USD | -13,824,000USD | — |
| Interest Income | — | 1,078,000USD | — | — | — | — | — | — |
| Interest Expense | — | 9,437,000USD | 4,731,000USD | 713,000USD | 603,000USD | 22,000USD | 99,000USD | 0USD |
| Net Interest Income | — | -8,359,000USD | — | — | — | — | — | — |
| Income Before Tax | — | -3,175,000USD | -40,484,000USD | 7,157,000USD | 31,887,000USD | 8,443,000USD | 6,531,000USD | -8,943,000USD |
| Income Tax Expense | — | 542,000USD | 163,000USD | -177,000USD | -177,000USD | -137,000USD | -88,000USD | -170,000USD |
| Net Income From Continuing Ops | — | 9,160,000USD | -30,222,000USD | 7,157,000USD | 33,362,000USD | 8,443,000USD | 6,531,000USD | -8,943,000USD |
| Ebit | — | 5,184,000USD | -35,773,000USD | 3,188,000USD | 33,965,000USD | 8,421,000USD | 6,432,000USD | -8,969,000USD |
| Ebitda | — | 5,720,000USD | -35,163,000USD | 3,412,000USD | 34,142,000USD | 8,558,000USD | 6,520,000USD | -8,825,000USD |
| Depreciation And Amortization | — | 536,000USD | 610,000USD | 224,000USD | 177,000USD | 137,000USD | 88,000USD | 144,000USD |
| Reconciled Depreciation | — | 536,000USD | 610,000USD | 224,000USD | 177,000USD | 137,000USD | 88,000USD | 144,000USD |
| Net Income Applicable To Common Shares | — | -3,175,000USD | -40,485,000USD | 7,157,000USD | 33,362,000USD | 8,443,000USD | 6,531,000USD | -10,250,000USD |
| Non Operating Income Net Other | — | — | 775,000USD | 1,454,000USD | 111,000USD | 22,000USD | 99,000USD | 13,000USD |
| Minority Interest | — | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Discontinued Operations | — | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20162016-12-31 · USD | FY 20112011-12-31 · USD | FY 20102010-12-31 · USD | FY 20092009-12-31 · USD | FY 20082008-12-31 · USD | FY 20072007-12-31 · USD | FY 20062006-12-31 · USD | FY 20052005-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 106,407,000USD | 4,000,000USD | 2,577,000USD | 81,538,000USD | 12,420,000USD | 13,622,000USD | 3,127,000USD | 8,912,000USD |
| Cost Of Revenue | 59,897,000USD | 49,475,000USD | 50,312,000USD | 53,445,000USD | 66,570,000USD | 67,280,000USD | 61,538,000USD | 50,483,000USD |
| Gross Profit | 46,510,000USD | 4,000,000USD | 2,577,000USD | 81,538,000USD | 12,420,000USD | 13,622,000USD | 3,127,000USD | 8,912,000USD |
| Research Development | 59,897,000USD | 37,182,000USD | 38,013,000USD | 39,840,000USD | 53,950,000USD | 53,388,000USD | 49,225,000USD | 40,570,000USD |
| Selling General Administrative | 27,823,000USD | 13,590,000USD | 14,199,000USD | 15,626,000USD | 15,076,000USD | 16,721,000USD | 15,240,000USD | 12,975,000USD |
| Unclassified Operating Expenses | -59,897,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 27,823,000USD | 50,772,000USD | 52,212,000USD | 55,466,000USD | 69,026,000USD | 70,109,000USD | 64,465,000USD | 53,545,000USD |
| Operating Income | 18,687,000USD | -47,964,000USD | -49,635,000USD | 26,095,000USD | -59,079,000USD | -56,487,000USD | -61,338,000USD | -44,633,000USD |
| Interest Income | 464,000USD | — | — | — | — | — | — | — |
| Interest Expense | 2,234,000USD | 104,000USD | 163,000USD | 409,000USD | 491,000USD | 699,000USD | 523,000USD | 535,000USD |
| Net Interest Income | -2,234,000USD | — | — | — | — | — | — | — |
| Income Before Tax | 16,453,000USD | -47,860,000USD | -49,463,000USD | 24,694,000USD | -56,374,000USD | -48,894,000USD | -57,115,000USD | -42,252,000USD |
| Income Tax Expense | -741,000USD | -209,000USD | -176,000USD | 150,000USD | -232,000USD | — | — | — |
| Tax Provision | 0USD | — | — | — | — | — | — | — |
| Net Income | 16,453,000USD | -47,860,000USD | -49,287,000USD | 24,544,000USD | -56,374,000USD | -48,894,000USD | -57,115,000USD | -42,252,000USD |
| Net Income From Continuing Ops | 16,453,000USD | -47,860,000USD | — | — | — | — | — | — |
| Ebit | 18,687,000USD | -47,821,000USD | -49,635,000USD | 25,103,000USD | -55,883,000USD | -48,195,000USD | -56,584,000USD | -41,743,000USD |
| Ebitda | 19,428,000USD | -46,524,000USD | -47,735,000USD | 27,124,000USD | -53,427,000USD | -45,366,000USD | -53,657,000USD | -38,681,000USD |
| Depreciation And Amortization | 741,000USD | 1,297,000USD | 1,900,000USD | 2,021,000USD | 2,456,000USD | 2,829,000USD | 2,927,000USD | 3,062,000USD |
| Total Other Income Expense Net | -2,234,000USD | 104,000USD | 172,000USD | -1,401,000USD | 232,000USD | 7,593,000USD | 4,223,000USD | 2,381,000USD |
| Non Operating Income Net Other | 464,000USD | 104,000USD | — | — | — | — | — | — |
| Minority Interest | 0USD | — | — | — | — | — | — | — |
| Discontinued Operations | 0USD | — | — | — | — | — | — | — |
| Net Income Applicable To Common Shares | 16,453,000USD | -50,717,000USD | — | 24,544,000USD | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,924,551,000USD | 1,273,478,000USD | 1,424,537,000USD | 1,436,557,000USD | 1,225,635,000USD | 1,264,051,000USD | 1,401,673,000USD | 1,436,060,000USD |
| Cash And Equivalents | 255,271,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 1,700,000,000USD | 818,550,000USD | 882,221,000USD | 962,535,000USD | 858,135,000USD | 938,218,000USD | 1,076,014,000USD | 1,011,692,000USD |
| Total Current Assets | 1,208,487,000USD | 839,465,000USD | 916,975,000USD | 977,349,000USD | 886,542,000USD | 956,053,000USD | 1,107,940,000USD | 1,018,601,000USD |
| Other Current Assets | 17,989,000USD | 13,934,000USD | 16,990,000USD | 13,006,000USD | 19,997,000USD | 15,823,000USD | 15,276,000USD | 6,665,000USD |
| Other Non Current Assets | 19,406,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 2,098,038,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 181,429,000USD | 199,185,000USD | 202,452,000USD | 142,144,000USD | 131,064,000USD | 159,726,000USD | 179,674,000USD | 109,812,000USD |
| Other Current Liabilities | 3,304,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | -173,487,000USD | -826,568,000USD | -659,625,000USD | -521,123,000USD | -368,720,000USD | -266,413,000USD | -135,372,000USD | -13,911,000USD |
| Total Equity Including Noncontrolling Interest | -173,487,000USD | — | — | — | — | — | — | — |
| Short Long Term Debt | 27,358,000USD | 44,808,000USD | 41,181,000USD | 17,280,000USD | 14,400,000USD | 12,960,000USD | 11,520,000USD | 11,520,000USD |
| Long Term Debt | 248,202,000USD | 1,117,720,000USD | 1,115,981,000USD | 1,048,271,000USD | 713,045,000USD | 645,168,000USD | 645,597,000USD | 644,498,000USD |
| Deferred Revenue | 1,653,000USD | — | — | — | — | — | — | — |
| Net Receivables | 24,432,000USD | 6,827,000USD | 17,764,000USD | 1,808,000USD | 8,410,000USD | 2,012,000USD | 16,650,000USD | 244,000USD |
| Inventory | 380,000USD | 154,000USD | — | — | — | — | — | -244,000USD |
| Property Plant Equipment Net | 151,812,000USD | 156,983,000USD | 155,173,000USD | 153,581,000USD | 146,339,000USD | 144,614,000USD | 140,973,000USD | 140,566,000USD |
| Accounts Payable | 20,510,000USD | 24,709,000USD | 22,337,000USD | 22,084,000USD | 16,228,000USD | 13,942,000USD | 20,369,000USD | 11,581,000USD |
| Short Term Debt | 21,042,000USD | 65,768,000USD | 60,292,000USD | 37,927,000USD | 33,985,000USD | 32,534,000USD | 30,498,000USD | 30,376,000USD |
| Common Stock | 138,000USD | 124,000USD | 123,000USD | 122,000USD | 119,000USD | 119,000USD | 118,000USD | 118,000USD |
| Retained Earnings | -3,891,512,000USD | -3,692,750,000USD | -3,486,719,000USD | -3,303,688,000USD | -2,997,510,000USD | -2,863,140,000USD | -2,701,764,000USD | -2,551,744,000USD |
| Accumulated Other Comprehensive Income | -3,826,000USD | -1,612,000USD | 630,000USD | 34,000USD | -158,000USD | 1,545,000USD | 2,398,000USD | 5,387,000USD |
| Total Liab | — | 2,100,046,000USD | 2,084,162,000USD | 1,957,680,000USD | 1,594,355,000USD | 1,530,464,000USD | 1,537,045,000USD | 1,449,971,000USD |
| Other Current Liab | — | 107,055,000USD | 118,211,000USD | 80,521,000USD | 79,507,000USD | 60,880,000USD | 76,437,000USD | 67,855,000USD |
| Capital Stock | — | 124,000USD | 123,000USD | 122,000USD | 119,000USD | 119,000USD | 118,000USD | 118,000USD |
| Cash | — | 129,843,000USD | 122,518,000USD | 225,467,000USD | 74,940,000USD | 73,680,000USD | 94,857,000USD | 46,888,000USD |
| Current Deferred Revenue | — | 1,653,000USD | 1,612,000USD | 1,612,000USD | 1,344,000USD | 52,370,000USD | 52,370,000USD | — |
| Net Debt | — | 1,158,880,000USD | 1,161,725,000USD | 971,386,000USD | 783,118,000USD | 717,375,000USD | 693,820,000USD | 742,738,000USD |
| Short Long Term Debt Total | — | 1,288,723,000USD | 1,284,243,000USD | 1,196,853,000USD | 858,058,000USD | 791,055,000USD | 788,677,000USD | 789,626,000USD |
| Long Term Investments | — | 254,719,000USD | 335,048,000USD | 288,817,000USD | 178,201,000USD | 150,687,000USD | 145,055,000USD | 269,168,000USD |
| Short Term Investments | — | 688,707,000USD | 759,703,000USD | 737,068,000USD | 783,195,000USD | 864,538,000USD | 981,157,000USD | 964,804,000USD |
| Property Plant Equipment Gross | — | 156,983,000USD | 202,474,000USD | 153,581,000USD | 146,339,000USD | 144,614,000USD | 178,150,000USD | 140,566,000USD |
| Common Stock Shares Outstanding | — | 123,273,000shares | 122,434,000shares | 119,982,000shares | 119,457,000shares | 118,496,000shares | 118,075,000shares | 117,685,000shares |
| Non Current Assets Total | — | 434,013,000USD | 507,562,000USD | 459,208,000USD | 339,093,000USD | 307,998,000USD | 293,733,000USD | 417,459,000USD |
| Non Current Liabilities Total | — | 1,900,861,000USD | 1,881,710,000USD | 1,815,536,000USD | 1,463,291,000USD | 1,370,738,000USD | 1,357,371,000USD | 1,340,159,000USD |
| Non Current Liabilities Other | — | 677,906,000USD | 657,759,000USD | 656,610,000USD | 639,218,000USD | 612,217,000USD | 599,192,000USD | 580,909,000USD |
| Non Currrent Assets Other | — | 22,311,000USD | 17,341,000USD | 16,810,000USD | 14,553,000USD | 12,697,000USD | 7,705,000USD | 7,725,000USD |
| Net Working Capital | — | 640,280,000USD | 714,523,000USD | 835,205,000USD | 755,478,000USD | 796,327,000USD | 928,266,000USD | 908,789,000USD |
| Unclassified Current Liabilities | — | -44,808,000USD | -41,181,000USD | -17,280,000USD | -14,400,000USD | -12,960,000USD | -11,520,000USD | -11,520,000USD |
| Unclassified Non Current Liabilities | — | 105,235,000USD | 107,970,000USD | 110,655,000USD | 111,028,000USD | 113,353,000USD | 112,582,000USD | 114,752,000USD |
| Unclassified Equity | — | 2,867,546,000USD | 2,826,218,000USD | 2,782,287,000USD | 2,628,710,000USD | 2,594,944,000USD | 2,563,758,000USD | 2,532,210,000USD |
| Other Assets | — | — | — | — | — | — | — | 1USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,424,537,000USD | 1,401,673,000USD | 824,316,000USD | 1,014,775,000USD | 841,319,000USD | 533,803,000USD | 289,814,000USD | 211,178,000USD |
| Other Current Assets | 16,990,000USD | 15,276,000USD | 11,944,000USD | 12,462,000USD | 12,215,000USD | 5,741,000USD | 3,477,000USD | 2,158,000USD |
| Total Liab | 2,084,162,000USD | 1,537,045,000USD | 1,210,639,000USD | 1,122,675,000USD | 597,456,000USD | 420,420,000USD | 300,751,000USD | 185,244,000USD |
| Total Stockholder Equity | -659,625,000USD | -135,372,000USD | -386,323,000USD | -107,900,000USD | 243,863,000USD | 113,383,000USD | -10,937,000USD | 25,934,000USD |
| Other Current Liab | 118,211,000USD | 76,437,000USD | 53,200,000USD | 45,219,000USD | 35,910,000USD | 20,364,000USD | 13,247,000USD | 15,823,000USD |
| Common Stock | 123,000USD | 118,000USD | 102,000USD | 94,000USD | 84,000USD | 70,000USD | 59,000USD | 768,758,000USD |
| Capital Stock | 123,000USD | 118,000USD | 102,000USD | 94,000USD | 84,000USD | 70,000USD | 59,000USD | 55,000USD |
| Retained Earnings | -3,486,719,000USD | -2,701,764,000USD | -2,112,238,000USD | -1,585,994,000USD | -1,207,620,000USD | -992,306,000USD | -865,016,000USD | -743,324,000USD |
| Cash | 122,518,000USD | 94,857,000USD | 113,024,000USD | 65,582,000USD | 112,666,000USD | 82,985,000USD | 36,433,000USD | 42,256,000USD |
| Cash And Short Term Investments | 882,221,000USD | 1,076,014,000USD | 614,824,000USD | 782,577,000USD | 471,638,000USD | 464,060,000USD | 225,112,000USD | 198,731,000USD |
| Total Current Assets | 916,975,000USD | 1,107,940,000USD | 628,051,000USD | 795,186,000USD | 535,672,000USD | 474,221,000USD | 233,752,000USD | 207,674,000USD |
| Total Current Liabilities | 202,452,000USD | 179,674,000USD | 102,678,000USD | 84,617,000USD | 71,860,000USD | 31,199,000USD | 26,023,000USD | 22,194,000USD |
| Current Deferred Revenue | 1,612,000USD | 52,370,000USD | 17,891,000USD | — | 34,370,000USD | 19,315,000USD | 12,123,000USD | 15,757,000USD |
| Net Debt | 1,161,725,000USD | 693,820,000USD | 642,747,000USD | 684,718,000USD | 157,264,000USD | 55,953,000USD | 99,635,000USD | 157,000USD |
| Short Term Debt | 60,292,000USD | 30,498,000USD | 27,971,000USD | 13,787,000USD | 14,863,000USD | 2,785,000USD | 4,616,000USD | 2,607,000USD |
| Short Long Term Debt | 41,181,000USD | 11,520,000USD | 10,080,000USD | 958,000USD | — | — | — | 2,607,000USD |
| Short Long Term Debt Total | 1,284,243,000USD | 788,677,000USD | 755,771,000USD | 750,300,000USD | 269,930,000USD | 138,938,000USD | 136,068,000USD | 42,413,000USD |
| Long Term Debt | 1,115,981,000USD | 645,597,000USD | 607,373,000USD | 63,810,000USD | 47,367,000USD | 46,209,000USD | 45,052,000USD | 39,806,000USD |
| Long Term Investments | 335,048,000USD | 145,055,000USD | 40,534,000USD | 46,708,000USD | 152,050,000USD | 36,954,000USD | 42,650,000USD | 0USD |
| Short Term Investments | 759,703,000USD | 981,157,000USD | 501,800,000USD | 716,995,000USD | 358,972,000USD | 381,075,000USD | 188,679,000USD | 156,475,000USD |
| Net Receivables | 17,764,000USD | 16,650,000USD | 1,283,000USD | 147,000USD | 51,819,000USD | 4,420,000USD | 5,163,000USD | 6,785,000USD |
| Accounts Payable | 22,337,000USD | 20,369,000USD | 21,507,000USD | 25,611,000USD | 21,087,000USD | 8,050,000USD | 8,160,000USD | 3,764,000USD |
| Property Plant Equipment Net | 155,173,000USD | 140,973,000USD | 147,735,000USD | 163,190,000USD | 146,409,000USD | 16,270,000USD | 13,412,000USD | 3,204,000USD |
| Property Plant Equipment Gross | 202,474,000USD | 178,150,000USD | 176,083,000USD | 163,190,000USD | 146,409,000USD | 22,628,000USD | 13,412,000USD | 3,204,000USD |
| Accumulated Other Comprehensive Income | 630,000USD | 2,398,000USD | -10,000USD | -3,590,000USD | -869,000USD | 149,000USD | 679,000USD | 500,000USD |
| Common Stock Shares Outstanding | 120,103,000shares | 111,979,000shares | 96,524,000shares | 89,825,000shares | 76,886,000shares | 64,524,000shares | 57,575,000shares | 54,420,000shares |
| Non Current Assets Total | 507,562,000USD | 293,733,000USD | 196,265,000USD | 219,589,000USD | 305,647,000USD | 59,582,000USD | 56,062,000USD | 3,504,000USD |
| Non Current Liabilities Total | 1,881,710,000USD | 1,357,371,000USD | 1,107,961,000USD | 1,038,058,000USD | 525,596,000USD | 389,221,000USD | 274,728,000USD | 163,050,000USD |
| Non Current Liabilities Other | 657,759,000USD | 599,192,000USD | 380,161,000USD | 974,248,000USD | 391,229,000USD | 256,012,000USD | 229,676,000USD | 123,244,000USD |
| Non Currrent Assets Other | 17,341,000USD | 7,705,000USD | 7,996,000USD | 9,691,000USD | 7,188,000USD | 6,358,000USD | 8,882,000USD | 300,000USD |
| Net Working Capital | 714,523,000USD | 928,266,000USD | 525,373,000USD | 710,569,000USD | 463,812,000USD | 443,022,000USD | 207,729,000USD | 185,480,000USD |
| Unclassified Current Liabilities | -41,181,000USD | -11,520,000USD | -27,971,000USD | — | -34,370,000USD | -19,315,000USD | -12,123,000USD | -18,364,000USD |
| Unclassified Non Current Liabilities | 107,970,000USD | 112,582,000USD | 120,427,000USD | -300,544,000USD | -270,529,000USD | -253,068,000USD | -143,276,000USD | -122,473,000USD |
| Unclassified Equity | 2,826,218,000USD | 2,563,758,000USD | 1,725,721,000USD | 1,481,496,000USD | 1,452,184,000USD | 1,105,400,000USD | 853,282,000USD | — |
| Inventory | — | — | -11,944,000USD | -147,000USD | -51,819,000USD | -4,420,000USD | — | -6,785,000USD |
| Other Liab | — | — | — | 300,544,000USD | 270,529,000USD | 253,068,000USD | 143,276,000USD | 122,473,000USD |
| Other Assets | — | — | — | 9,691,000USD | 7,188,000USD | 46,236,000USD | — | 300,000USD |
| Net Tangible Assets | — | — | — | -107,900,000USD | 243,863,000USD | 113,383,000USD | -10,937,000USD | 25,934,000USD |
| Unclassified Non Current Assets | — | — | — | -9,691,000USD | -7,188,000USD | -46,236,000USD | -8,882,000USD | — |
| Deferred Long Term Liab | — | — | — | — | 87,000,000USD | 87,000,000USD | — | 0USD |
| Intangible Assets | — | — | — | — | — | — | — | 0USD |
| Good Will | — | — | — | — | — | — | — | 0USD |
| Additional Paid In Capital | — | — | — | — | — | — | — | 0USD |
| Treasury Stock | — | — | — | — | — | — | — | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 7,009,000USD |
| Stock Based Compensation | 66,105,000USD |
| Change To Account Receivables | -6,668,000USD |
| Change To Inventory | -5,823,000USD |
| Change To Liabilities | -8,031,000USD |
| Change In Working Capital | -15,236,000USD |
| Operating Cash Flow | -305,297,000USD |
| Capital Expenditures | -10,264,000USD |
| Net Investments | -351,242,000USD |
| Investing Cash Flow | -361,506,000USD |
| Net Debt Issuance | -6,329,000USD |
| Common Stock Issuance | 49,348,000USD |
| Net Common Stock Issuance | -2,327,000USD |
| Unclassified Financing Cash Flow | 759,935,000USD |
| Financing Cash Flow | 800,627,000USD |
| Effect Of Forex Changes On Cash | -1,078,000USD |
| Change In Cash | 132,746,000USD |
| End Cash Flow | 258,378,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -206,031,000USD | -183,031,000USD | -306,178,000USD | -134,370,000USD | -161,376,000USD | -150,020,000USD | -160,545,000USD | -143,318,000USD |
| Depreciation | 3,378,000USD | 2,861,000USD | 2,679,000USD | 2,285,000USD | 2,300,000USD | 2,383,000USD | 2,411,000USD | 2,406,000USD |
| Stock Based Compensation | 30,394,000USD | 30,506,000USD | 30,696,000USD | 27,535,000USD | 23,549,000USD | 26,250,000USD | 25,356,000USD | 24,622,000USD |
| Other Non Cash Items | 27,021,000USD | 39,364,000USD | 142,767,000USD | 27,425,000USD | 9,113,000USD | 14,103,000USD | 21,394,000USD | 7,210,000USD |
| Change To Account Receivables | 10,937,000USD | -15,956,000USD | 6,602,000USD | -6,398,000USD | 14,638,000USD | -16,405,999USD | -244,000USD | 834,000USD |
| Change To Inventory | -3,567,000USD | — | — | — | 0USD | — | — | — |
| Change In Working Capital | -219,000USD | -1,845,000USD | 22,531,000USD | -51,111,000USD | -5,203,000USD | 41,714,000USD | 9,884,000USD | 9,767,000USD |
| Total Cash From Operating Activities | -145,457,000USD | -142,650,999USD | -107,505,000USD | -128,236,000USD | -131,616,999USD | -65,569,999USD | -101,500,000USD | -99,313,000USD |
| Capital Expenditures | -5,930,000USD | -5,644,000USD | -9,354,000USD | -4,145,000USD | -5,664,000USD | -1,290,000USD | -2,455,000USD | -1,915,000USD |
| Free Cash Flow | -151,387,000USD | -148,294,999USD | -116,859,000USD | -132,381,000USD | -137,281,000USD | -66,860,000USD | -103,955,000USD | -101,228,000USD |
| Investments | 151,422,000USD | -65,548,000USD | -70,979,000USD | 52,881,000USD | 105,956,000USD | 110,863,000USD | -45,053,000USD | -651,548,000USD |
| Total Cashflows From Investing Activities | 145,492,000USD | -71,192,000USD | -70,979,000USD | 52,881,000USD | 105,956,000USD | 110,863,000USD | -45,053,000USD | -651,548,000USD |
| Net Borrowings | -2,735,000USD | -2,722,000USD | 324,251,000USD | -2,698,000USD | -2,884,000USD | -2,914,000USD | -2,894,000USD | — |
| Total Cash From Financing Activities | 7,770,000USD | 110,705,000USD | 330,466,000USD | 78,533,000USD | 4,754,000USD | 2,384,000USD | 3,425,000USD | 821,011,000USD |
| Sale Purchase Of Stock | 11,346,000USD | — | 21,331,000USD | 14,396,000USD | — | — | 17,004,000USD | — |
| Change In Cash | 7,322,000USD | -102,947,000USD | 152,028,000USD | 2,496,000USD | -21,177,000USD | 47,969,000USD | -143,254,000USD | 70,166,000USD |
| Begin Period Cash Flow | 125,632,000USD | 228,579,000USD | 76,551,000USD | 74,055,000USD | 95,232,000USD | 47,263,000USD | 190,517,000USD | 120,351,000USD |
| End Period Cash Flow | 132,954,000USD | 125,632,000USD | 228,579,000USD | 76,551,000USD | 74,055,000USD | 95,232,000USD | 47,263,000USD | 190,517,000USD |
| Other Cashflows From Financing Activities | -841,000USD | -76,221,000USD | -720,000USD | 74,486,000USD | -13,000USD | -1,182,000USD | 6,319,000USD | 210,685,000USD |
| Issuance Of Capital Stock | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 613,204,000USD |
| Other Cashflows From Investing Activities | — | 5,000,000USD | — | -5,000,000USD | — | — | 1,754,000USD | -649,633,000USD |
| Unclassified Operating Cash Flow | — | -30,505,999USD | — | — | — | — | — | — |
| Unclassified Investing Cash Flow | — | -5,000,000USD | 9,354,000USD | 9,145,000USD | 5,664,000USD | 1,290,000USD | — | 651,548,000USD |
| Unclassified Financing Cash Flow | — | 189,648,000USD | -14,396,000USD | -7,651,000USD | 7,651,000USD | 6,480,000USD | -17,004,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -784,955,000USD | -589,526,000USD | -526,244,000USD | -388,955,000USD | -215,314,000USD | -127,290,000USD | -121,692,000USD | -106,289,000USD |
| Depreciation | 10,125,000USD | 9,531,000USD | 11,892,000USD | 5,814,000USD | 2,276,000USD | 1,831,000USD | 1,293,000USD | 1,239,000USD |
| Stock Based Compensation | 112,286,000USD | 97,840,000USD | 72,065,000USD | 47,853,000USD | 26,832,000USD | 17,620,000USD | 10,759,000USD | 9,761,000USD |
| Other Non Cash Items | 188,163,000USD | 50,601,000USD | 24,865,000USD | 60,476,000USD | 32,384,000USD | 28,238,000USD | 22,621,000USD | 17,010,000USD |
| Change To Account Receivables | -1,114,000USD | -15,367,000USD | -1,136,000USD | 56,672,000USD | -47,399,000USD | 743,000USD | 1,622,000USD | -1,119,000USD |
| Change In Working Capital | -35,628,000USD | 35,664,000USD | 3,089,000USD | -24,704,000USD | 8,456,000USD | 89,117,000USD | -3,888,000USD | -22,936,000USD |
| Total Cash From Operating Activities | -510,009,000USD | -395,890,000USD | -414,333,000USD | -299,516,000USD | -142,522,000USD | 8,943,000USD | -90,907,000USD | -101,215,000USD |
| Capital Expenditures | -24,807,000USD | -3,906,000USD | -1,416,000USD | -11,335,000USD | -48,872,000USD | -11,052,000USD | -2,619,000USD | -889,000USD |
| Free Cash Flow | -534,816,000USD | -399,796,000USD | -415,749,000USD | -310,851,000USD | -191,394,000USD | -2,109,000USD | -93,526,000USD | -102,104,000USD |
| Investments | 41,473,000USD | -553,097,000USD | 349,913,000USD | -250,799,000USD | -98,905,000USD | -185,463,000USD | -72,088,000USD | 6,008,000USD |
| Total Cashflows From Investing Activities | 16,666,000USD | -553,097,000USD | 239,253,000USD | -262,134,000USD | -147,777,000USD | -196,515,000USD | -74,707,000USD | 5,133,000USD |
| Net Borrowings | 315,947,000USD | -9,618,000USD | -858,000USD | 473,526,000USD | 334,661,000USD | 334,661,000USD | 1,710,000USD | 9,898,000USD |
| Total Cash From Financing Activities | 524,458,000USD | 930,611,000USD | 221,317,000USD | 516,166,000USD | 319,980,000USD | 234,124,000USD | 159,791,000USD | 13,132,000USD |
| Issuance Of Capital Stock | 0USD | 706,844,000USD | 1,312,000USD | 15,144,000USD | 312,049,000USD | 225,108,000USD | 36,214,000USD | 0USD |
| Change In Cash | 30,400,000USD | -18,167,000USD | 46,217,000USD | -45,484,000USD | 29,681,000USD | 46,552,000USD | -5,823,000USD | -82,950,000USD |
| Begin Period Cash Flow | 95,232,000USD | 113,399,000USD | 67,182,000USD | 112,666,000USD | 82,985,000USD | 36,433,000USD | 42,256,000USD | 125,206,000USD |
| End Period Cash Flow | 125,632,000USD | 95,232,000USD | 113,399,000USD | 67,182,000USD | 112,666,000USD | 82,985,000USD | 36,433,000USD | 42,256,000USD |
| Other Cashflows From Investing Activities | -5,000,000USD | — | — | -250,799,000USD | -98,905,000USD | -185,463,000USD | -72,088,000USD | 14,000USD |
| Other Cashflows From Financing Activities | -2,468,000USD | 233,385,000USD | 57,942,000USD | 163,962,000USD | 7,931,000USD | 9,016,000USD | -11,993,000USD | 3,234,000USD |
| Unclassified Investing Cash Flow | 5,000,000USD | — | -109,244,000USD | 250,799,000USD | 98,905,000USD | 185,463,000USD | 72,088,000USD | — |
| Unclassified Financing Cash Flow | 210,979,000USD | 653,828,000USD | 193,209,000USD | -138,865,000USD | -18,163,000USD | -107,298,000USD | 132,467,000USD | -3,234,000USD |
| Sale Purchase Of Stock | — | 53,016,000USD | -10,517,000USD | 17,543,000USD | -4,449,000USD | -2,255,000USD | 37,607,000USD | 3,234,000USD |
| Dividends Paid | — | — | -18,459,000USD | — | — | — | — | 0USD |
| Change To Liabilities | — | — | — | -75,690,000USD | 19,764,000USD | 94,007,000USD | 2,228,000USD | -3,553,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -45,484,000USD | 29,681,000USD | 46,552,000USD | -5,823,000USD | -82,950,000USD |
| Unclassified Operating Cash Flow | — | — | — | — | 2,844,000USD | — | — | — |
| Change To Inventory | — | — | — | — | — | 1,484,000USD | -5,352,000USD | 4,908,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Product | Collaboration Revenues | 2,637,000 | USD | 0001193125-26-206364 |
| Q1 2026Quarterly · 2026-03-31 | Product | License And Milestone Revenues | 11,929,000 | USD | 0001193125-26-206364 |
| Q1 2026Quarterly · 2026-03-31 | Product | Net Product Revenue | 4,789,000 | USD | 0001193125-26-206364 |
| FY 2025Yearly · 2025-12-31 | Product | Collaboration Revenues | 8,686,000 | USD | 0001193125-26-076495 |
| FY 2025Yearly · 2025-12-31 | Product | License And Milestone Revenues | 79,353,000 | USD | 0001193125-26-076495 |
| Q3 2025Quarterly · 2025-09-30 | Product | Collaboration Revenues | 1,936,000 | USD | 0001193125-25-267059 |
| Q3 2025Quarterly · 2025-09-30 | Product | License And Milestone Revenues | 0 | USD | 0001193125-25-267059 |
| Q2 2025Quarterly · 2025-06-30 | Product | Collaboration Revenues | 2,416,000 | USD | 0000950170-25-105108 |
| Q2 2025Quarterly · 2025-06-30 | Product | License And Milestone Revenues | 64,353,000 | USD | 0000950170-25-105108 |
| Q1 2025Quarterly · 2025-03-31 | Product | Collaboration Revenues | 1,579,000 | USD | 0001193125-26-206364 |
| Q1 2025Quarterly · 2025-03-31 | Product | License And Milestone Revenues | 0 | USD | 0001193125-26-206364 |
| Q1 2025Quarterly · 2025-03-31 | Product | Net Product Revenue | 0 | USD | 0001193125-26-206364 |
| FY 2024Yearly · 2024-12-31 | Product | Collaboration Revenues | 3,474,000 | USD | 0000950170-25-029206 |
| FY 2024Yearly · 2024-12-31 | Product | License And Milestone Revenues | 15,000,000 | USD | 0000950170-25-029206 |
| FY 2024Yearly · 2024-12-31 | Product | Realization Of Revenue Participation Right Purchase Agreement | 0 | USD | 0000950170-25-029206 |
| Q3 2024Quarterly · 2024-09-30 | Product | Collaboration Revenues | 463,000 | USD | 0001193125-25-267059 |
| Q3 2024Quarterly · 2024-09-30 | Product | License And Milestone Revenues | 0 | USD | 0001193125-25-267059 |
| Q2 2024Quarterly · 2024-06-30 | Product | Collaboration Revenues | 200,000 | USD | 0000950170-25-105108 |
| Q2 2024Quarterly · 2024-06-30 | Product | License And Milestone Revenues | 0 | USD | 0000950170-25-105108 |
| Q2 2024Quarterly · 2024-06-30 | Product | Other | 49,000 | USD | 0000950170-25-105108 |
| Q1 2024Quarterly · 2024-03-31 | Product | Milestone | 0 | USD | 0000950170-24-057805 |
| Q1 2024Quarterly · 2024-03-31 | Product | Research And Development | 835,000 | USD | 0000950170-24-057805 |
| Q4 2023Quarterly · 2023-12-31 | Product | Milestone | 1,000,000 | USD | Legacy provider |
| Q4 2023Quarterly · 2023-12-31 | Product | Research And Development | 672,000 | USD | Legacy provider |
| FY 2023Yearly · 2023-12-31 | Product | License | 0 | USD | 0000950170-24-022256 |
| FY 2023Yearly · 2023-12-31 | Product | Milestone | 3,500,000 | USD | 0000950170-24-022256 |
| FY 2023Yearly · 2023-12-31 | Product | Realization Of Revenue Participation Right Purchase Agreement | 0 | USD | 0000950170-24-022256 |
| FY 2023Yearly · 2023-12-31 | Product | Research And Development | 4,030,000 | USD | 0000950170-24-022256 |
| FY 2023Yearly · 2023-12-31 | Product | Research And Development Milestone Grant And Other Revenues Net | 0 | USD | 0000950170-24-022256 |
| FY 2022Yearly · 2022-12-31 | Product | License | 0 | USD | 0000950170-24-022256 |
| FY 2022Yearly · 2022-12-31 | Product | Milestone | 1,000,000 | USD | 0000950170-24-022256 |
| FY 2022Yearly · 2022-12-31 | Product | Realization Of Revenue Participation Right Purchase Agreement | 87,000,000 | USD | 0000950170-24-022256 |
| FY 2022Yearly · 2022-12-31 | Product | Research And Development | 6,588,000 | USD | 0000950170-24-022256 |
| FY 2022Yearly · 2022-12-31 | Product | Research And Development Milestone Grant And Other Revenues Net | 0 | USD | 0000950170-24-022256 |
| FY 2017Yearly · 2017-12-31 | Product | Co Invest Option Payments | -20,000,000 | USD | 0001564590-19-006580 |
| FY 2017Yearly · 2017-12-31 | Product | License | 8,799,000 | USD | 0001564590-19-006580 |
| FY 2017Yearly · 2017-12-31 | Product | Milestone Fees | 11,000,000 | USD | 0001564590-19-006580 |
| FY 2017Yearly · 2017-12-31 | Product | Reimbursements | 13,213,000 | USD | 0001564590-19-006580 |
| FY 2017Yearly · 2017-12-31 | Product | Research And Development Grant And Other Revenues Net | 7,721,000 | USD | 0001564590-19-006580 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.